Most rotator-cuff tears are degenerative, atraumatic, and more prevalent with age. Nonoperative treatment, including physical ...

CME activities, cases, challenges, videos, and more teaching and learning tools from the New England Journal of Medicine.

Currently licensed and approved malaria subunit vaccines provide modest, short-lived protection against malaria. Immunization with live-attenuated Plasmodium falciparum malaria parasites is an ...

Dr. Mallory C. Mandel (Pediatrics): A 16-year-old girl was admitted to this hospital because of abdominal pain. The patient had been in her usual state of health until 4 weeks before the current ...

Genomic sequencing technology allows for identification of reproductive couples with an increased chance, as compared with that in the general population, of having a child with an autosomal ...

Shown is the spatial distribution of annual average population-weighted flood days across the globe from 1985 to 2000 (Panel A) and from 2001 to 2021 (Panel B) and the change in days between the ...

Patients receiving standard treatment for chronic subdural hematoma have a high risk of treatment failure. The effect of adjunctive middle meningeal artery embolization on the risk of treatment ...

A man with monoclonal gammopathy of undetermined significance and thrombosis was found to have a previously undetected pathogenic monoclonal antibody that activated platelets in a PF4-dependent manner ...

Author: The BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and ...

In patients with chronic subdural hematoma, the incidence of recurrence or progression remains high despite standard care. The effect of adding middle meningeal artery embolization to treatment is ...

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions.

In this phase 2 dose-finding study, we evaluated the safety and efficacy of oral infigratinib in children with achondroplasia between the ages of 3 and 11 years. A total of 72 children were ...